VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
-19.25%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$585M
AUM Growth
+$585M
(-34%)
Cap. Flow
-$154M
Cap. Flow
% of AUM
-26.37%
Top 10 Holdings %
Top 10 Hldgs %
61.33%
Holding
425
New
84
Increased
85
Reduced
101
Closed
119
Top Buys
| 1 |
Energy Transfer Partners
ET
|
$43.7M |
| 2 |
Enterprise Products Partners
EPD
|
$7.86M |
| 3 |
Oneok
OKE
|
$7.26M |
| 4 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
$2.37M |
| 5 |
AM
ANTERO MIDSTREAM PARTNERS LP
AM
|
$2.31M |
Top Sells
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$77.3M |
| 2 |
Marathon Petroleum
MPC
|
$24.9M |
| 3 |
EEP
Enbridge Energy Partners
EEP
|
$23.6M |
| 4 |
Phillips 66
PSX
|
$14.9M |
| 5 |
Williams Companies
WMB
|
$14.7M |
Sector Composition
| 1 | Energy | 82.73% |
| 2 | Healthcare | 7.29% |
| 3 | Utilities | 2.06% |
| 4 | Financials | 0.12% |
| 5 | Technology | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vertex Pharmaceuticals
VRTX
$100B
| $586K | 0.1% | 3,535 -1,516 | -30% | -$251K |
|
52
Halozyme
HALO
$8.56B
| $584K | 0.1% | 39,935 -1,264 | -3% | -$18.5K |
|
|
ACOR
53
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $578K | 0.1% | 37,111 +12,262 | +49% | +$191K |
|
54
Enanta Pharmaceuticals
ENTA
$180M
| $577K | 0.1% | 8,140 +1,088 | +15% | +$77.1K |
|
55
Incyte
INCY
$16.5B
| $577K | 0.1% | 9,073 +8,331 | +1,123% | +$530K |
|
56
Biogen
BIIB
$19.4B
| $574K | 0.1% | 1,909 -652 | -25% | -$196K |
|
57
Theravance Biopharma
TBPH
$699M
| $574K | 0.1% | 22,443 -9,783 | -30% | -$250K |
|
58
Alnylam Pharmaceuticals
ALNY
$58.5B
| $573K | 0.1% | 7,863 +3,436 | +78% | +$250K |
|
59
Ultragenyx Pharmaceutical
RARE
$2.89B
| $572K | 0.1% | 13,150 +3,709 | +39% | +$161K |
|
60
Exelixis
EXEL
$10.1B
| $567K | 0.1% | 28,817 -11,034 | -28% | -$217K |
|
|
XIFR
61
XPLR Infrastructure, LP
XIFR
$996M
| $566K | 0.1% | 13,149 | – | – |
|
|
CELG
62
DELISTED
Celgene Corp
CELG
| $566K | 0.1% | 8,835 -997 | -10% | -$63.9K |
|
|
SGEN
63
DELISTED
Seagen Inc. Common Stock
SGEN
| $565K | 0.1% | 9,963 -1,990 | -17% | -$113K |
|
64
Travere Therapeutics
TVTX
$1.56B
| $561K | 0.1% | 24,796 -3,271 | -12% | -$74K |
|
|
ICPT
65
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $560K | 0.1% | 5,560 -4,058 | -42% | -$409K |
|
|
CLVS
66
DELISTED
Clovis Oncology, Inc.
CLVS
| $555K | 0.09% | 30,876 +13,775 | +81% | +$248K |
|
67
Amicus Therapeutics
FOLD
$2.34B
| $550K | 0.09% | 57,427 +28,582 | +99% | +$274K |
|
68
BioMarin Pharmaceuticals
BMRN
$11.2B
| $549K | 0.09% | 6,453 -2,247 | -26% | -$191K |
|
|
ARRY
69
DELISTED
Array Biopharma Inc
ARRY
| $548K | 0.09% | 38,479 +12,195 | +46% | +$174K |
|
70
Ironwood Pharmaceuticals
IRWD
$214M
| $547K | 0.09% | 52,822 +10,692 | +25% | +$111K |
|
71
Lexicon Pharmaceuticals
LXRX
$400M
| $546K | 0.09% | 82,295 +21,567 | +36% | +$143K |
|
72
Nektar Therapeutics
NKTR
$568M
| $545K | 0.09% | 16,594 +2,717 | +20% | +$89.2K |
|
73
Sarepta Therapeutics
SRPT
$1.78B
| $543K | 0.09% | 4,976 -2,949 | -37% | -$322K |
|
74
Puma Biotechnology
PBYI
$254M
| $534K | 0.09% | 26,259 +12,032 | +85% | +$245K |
|
75
Agios Pharmaceuticals
AGIO
$2.19B
| $532K | 0.09% | 11,531 +3,316 | +40% | +$153K |
|